Pharmaceutical giant Merck is buying Verona Pharma, a company that concentrates its efforts on respiratory diseases, in an approximately $10 billion deal.

Merck & Co., Inc. (NYSE: MRK) is one of the 10 Best Value Stocks to Buy According to Billionaires. The company announced that the US FDA approved ENFLONSIA™ (clesrovimab-cfor) for the prevention ...

Both Eli Lilly LLY and Merck MRK are major players in the U.S. pharmaceutical industry, developing and commercializing therapies across oncology, immunology, and diabetes and cardiovascular areas ...

Merck MRK recently launched two late-stage clinical studies to evaluate MK-8527, its investigational once-monthly oral pill for HIV pre-exposure prophylaxis (PrEP).

Biotech deals originated from China are surging. Takeda touts a pair of OX2R phase 3 wins. Merck's PD-1xVEGF partner is being acquired.

Verona Pharma surged by 20.62 percent on Wednesday to end at $104.77 per share following news that it was being acquired by US-based pharmaceutical company Merck for $10 billion.

Robert Plant and Alison Krauss describe the "painful" experimentation process of their early days in the studio.

Panasonic opens largest-ever $4B EV plant in De Soto Panasonic is betting big on the future of EV manufacturing in the U.S., despite declining EV incentives and potential tariff setbacks.

We are learning more about plans to construct a 200-acre natural gas powered data center campus in Homer City.President Trump spoke Wednesday about plans to rep ...

Northwest Iowa home and garage are a total loss, after the improper disposal of fireworks after the Fourth of July.